Global Genomics Market 2025–2034

Reports Description

According to Custom Market Insights (CMI), The Global Genomics Market Size was valued at USD 38.23 Billion in 2024 and is expected to reach USD 44.22 Billion in 2025 and is estimated to reach USD 189.02 Billion by the end of 2034 at a CAGR of approximately 17.33% during the forecast period 2025-2034.

There has been a buoyant demand for the genomics market in recent years, primarily due to the impact of the outbreak of the COVID-19 pandemic. It showed staggering and unprecedented growth in recent years due to the outbreak of the COVID-19 pandemic. As a result, there was a sudden growth in the market due to increased demand. In addition, genomics has proved all its scientific abilities for treating, preventing, and managing various diseases.

To learn more about this report - request a sample report PDF

In recent years and the years to come, the market shall see a gradual shift towards precision medicines as compared to the conventional methods used for treatment, and this type of change is expected to play a significant part in the market's growth in the coming years.

Genome sequencing has become a vital tool for detecting various types of critical diseases like cancer. It is predicted that cancer cases are expected to increase during the forecast period, and it is about to grow to 29.5 million by the year 2040. And the death toll is expected to grow to about 16.4 million yearly. Therefore, the demand for DNA information analysis, sequencing, and storage will be highly beneficial in the coming years.

It will provide better products and software that will help meet the growing demand for genomics in the coming years. All these factors will help the market's growth during the forecast period.

Many new entrants in the market are expected to provide good opportunities for market growth in the coming years. Furthermore, as many service providers offer sequencing services, the market is expected to grow well in the coming years. In addition, there has been an increase in investments made in the research and development activities associated with bioinformatics. As a result, there will be positive growth in the market during the forecast period.

Growth Factors

The healthcare sector has seen a drastic change due to the outbreak of the pandemic in the past. Many nations worldwide were affected so that the market will grow well in the coming years. The Pharmaceutical industry and biotechnological organizations have engaged in research activities and invested a considerable amount in developing better vaccinations and safer and easier treatments for the COVID-19 pandemic. By monitoring and understanding the genome sequence, the spread of the virus, which affects humans, was studied, and its effect on the genome of humans was understood. This information is being used to develop enhanced treatments.

A few nations launched a set of laboratories in 2020 by collaborating with CDC Africa. Many countries like China, Nepal, Vietnam, and the United States studied gene structure. The virus's origin was traced, and the drugs were developed in the past. Significant market growth opportunities are expected to be provided due to the increase in the number of research activities conducted by the various institutes of various nations. Many startups are also engaged in the bio-informatics sector, which will provide significant opportunities for market growth in the coming years. Government funding for various nations has also increased the research and development activities are expected to grow.

The demand for different types of sequencing products is expected to grow in the coming years as research in the field has increased to a great extent. As the demand for personalized medicine has risen in recent years, it shall provide significant opportunities for the growth of the genomics market during the forecast period. Different pharmaceutical companies have increased the number of investments in the research activities associated with personalized medicines. These research activities will help the practitioners in the personalized medicine sector to detect the specific requirement of every patient, and the prescription of the drugs will be made for those cases. The treatments will also be decided based on the research made by the medical practitioners.

The outcomes of such practice provide guaranteed results. There has also been a large number of advancements in the gene therapy field, and it has a high potential to replace the currently used drugs and the performance of various surgeries for treating patients. Cost-saving therapy is one of the significant factors that will help in the growth of the market in the coming years. Patient compliance is another factor that will increase the demand for gene therapy in the coming years. It provides drug safety and early detection, which could be life-saving for the patient, and all of these factors will help in the market's growth in the coming years.

The therapies used for various patients could be personalized or optimized based on the need for the cure or the treatment. Microarray technologies have also proved to be a revolutionary advancement in personalized medicine, which will help grow the market in the coming years. In addition, for clinical testing, new drugs are developed by research organizations and pharmaceutical organizations on a larger scale.

Genomics market segment based on Application

Based on Application, the functional genomics segment is expected to have a larger market share in the coming years. The feature had a good amount of claims in terms of revenue which was about 32% in the past, and it will continue to grow well in the coming years. Maximum revenue was generated through the RTPCR tests conducted in the past.

The fastest compound annual growth rate will be registered through the pathway analysis segment in the coming years. It is a significant part of the research associated with life sciences and the development of drugs. People engaged in the research field use pathway analysis extensively to ensure an enhanced understanding of molecular and cellular biology.

Genomics market segment based on the Deliverables

Based on deliverables, the product segment will have a larger market share. It had a share of about 69% in the past and will continue to grow well in the coming years. Maximum revenue will be generated by launching the nucleic acid extraction reagents. Most of the market players in the genomics market are engaged in acquiring smaller companies to improve their market share.

Genomics market segment based on the End User

The pharmaceutical and biotechnology segment is expected to grow well in the coming years. Their market share is expected to be higher than the other end-user industries. It held a share of about 60% in the past and will continue to grow well in the coming years.

The demand for genomics technologies in the biotechnology and pharmaceutical industry has increased as the number of research activities conducted in this field has also increased. Many companies are offering genomics tests that are directly provided to consumers, and this is increased in recent years, due to which there has been a change in the business models. Pharmaceutical companies receive genomics data from companies that deal with personal genomics, and as data acquisition has become cheap, many new market players have entered the market as there has been a good demand in recent years.

Report Scope

Regional Insights

Based on geography, the North American region will have a larger market share in the coming years. This region has had a good share in the past, estimated at 36% in revenue, and will continue to grow. Strategic partnerships have also played an essential role in the market's growth in the North American region.

Funds provided by public and private organizations in the North American part will help increase such activities. In addition, many major companies in this field are in the North American region and will help grow the market in the coming years. As that has also been an increase in the approvals from the regulatory authorities of the North American region, the market will continue to grow in the coming years.

The availability of favorable reimbursement policies and change in the regulations that support the market is expected to provide significant opportunities for market growth in the coming years.

Imagenetics received support from organizations like Northshore University's health system and Color genomics to improve decision-making. The Asia Pacific region is also expected to grow well in the coming years.

The genomics market is expected to grow as research organizations take several initiatives. Research programs undertaken by the organizations in the make sure Pacific region will help in the growth of the market in the coming years. To enable genetic discoveries in Asia, a project was started which was named GenomeAsia 100K. About four various countries throughout Asia were studied under this project.

The regulatory bodies support the market's growth, which will be a significant factor that will help the market's growth as the number of approvals in this field has also increased in recent years. In the European region, the demand for genomics is expected to grow, and the growing population in this region will provide excellent opportunities for the market.

To ensure food safety and nutritional security, the market will continue to grow in the coming years. The regulatory framework in the European region has been modified to improve the research work in this area. As a result, the revenue generated by the market in the European region will grow in the coming years.

Key Players

• Thermo Fisher Scientific Inc.
• Agilent Technologies
• Pacific Biosciences of California Inc.
• QIAGEN N.V.
• Quest diagnostics
• Myriad Genetics, Inc.
• Eppendorf AG
• Beijing Genomics Institute (BGI)
• Bio-Rad Laboratories
• Danaher Corporation
• Hoffmann-La Roche Ltd.
• GE Healthcare
• Illumina Inc.
• Oxford Nanopore Technologies
• Eurofins Scientific
• Color
• 23andMe Inc.

Recent Development

• GRAIL was acquired by Illumina in the year 2021 with the aim of making available the DNA sequencing test to a large base of consumers.
• A new product was launched in the year 2020 by Nebula Genomics which would offer the entire genome sequencing to customers at a price of U.S. dollars 299.

Segments covered in the report

By Application

• Functional genomics
• Pathway analysis
• Biomarker discovery
• Epigenetics
• Others

By Deliverables

• Products
• Services

By End User

• Pharmaceutical and biotechnology companies
• Clinics and hospitals
• Government institutes and academic institutes
• Clinical research
• Others

On the basis of Geography

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America